These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 7515972)

  • 41. Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice.
    Scoggins RM; Taylor JR; Patrie J; van't Wout AB; Schuitemaker H; Camerini D
    J Virol; 2000 Apr; 74(7):3205-16. PubMed ID: 10708437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.
    Iversen AK; Shpaer EG; Rodrigo AG; Hirsch MS; Walker BD; Sheppard HW; Merigan TC; Mullins JI
    J Virol; 1995 Sep; 69(9):5743-53. PubMed ID: 7637019
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Syncytium induction by fresh HIV isolates: quantitative analysis using a transactivation beta-gal assay.
    Emilie D; Maillot MC; Bonnerot C; Devergne O; Delfraissy JF; Nicolas JF; Galanaud P
    AIDS; 1990 Aug; 4(8):791-7. PubMed ID: 1979746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary subtype C HIV-1 infection in Harare, Zimbabwe.
    Tien PC; Chiu T; Latif A; Ray S; Batra M; Contag CH; Zejena L; Mbizvo M; Delwart EL; Mullins JI; Katzenstein DA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):147-53. PubMed ID: 10048901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro.
    Saha K; Bentsman G; Chess L; Volsky DJ
    J Virol; 1998 Jan; 72(1):876-81. PubMed ID: 9420304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS.
    Abebe A; Demissie D; Goudsmit J; Brouwer M; Kuiken CL; Pollakis G; Schuitemaker H; Fontanet AL; Rinke de Wit TF
    AIDS; 1999 Jul; 13(11):1305-11. PubMed ID: 10449282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.
    Picchio GR; Gulizia RJ; Wehrly K; Chesebro B; Mosier DE
    J Virol; 1998 Mar; 72(3):2002-9. PubMed ID: 9499054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.
    Herbein G; Montaner LJ; Gordon S
    J Virol; 1996 Nov; 70(11):7388-97. PubMed ID: 8892857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma.
    Lo SC; Tsai S; Benish JR; Shih JW; Wear DJ; Wong DM
    Science; 1991 Mar; 251(4997):1074-6. PubMed ID: 1705362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants.
    Dedera D; Ratner L
    J Virol; 1991 Nov; 65(11):6129-36. PubMed ID: 1717715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.
    Spina CA; Guatelli JC; Richman DD
    J Virol; 1995 May; 69(5):2977-88. PubMed ID: 7707524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
    Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance against syncytium-inducing human immunodeficiency virus type 1 (HIV-1) in selected CD4(+) T cells from an HIV-1-infected nonprogressor: evidence of a novel pathway of resistance mediated by a soluble factor(s) that acts after virus entry.
    Saha K; Volsky DJ; Matczak E
    J Virol; 1999 Sep; 73(9):7891-8. PubMed ID: 10438887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression.
    Koenig S; Conley AJ; Brewah YA; Jones GM; Leath S; Boots LJ; Davey V; Pantaleo G; Demarest JF; Carter C
    Nat Med; 1995 Apr; 1(4):330-6. PubMed ID: 7585062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals.
    Llano A; Barretina J; Gutiérrez A; Blanco J; Cabrera C; Clotet B; Esté JA
    J Virol; 2001 Nov; 75(21):10319-25. PubMed ID: 11581400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study of viral replication in HIV-1-infected CEM T-cell subclones which are reduced in their ability to form syncytia.
    Gruber MF; Hewlett IK; Simms T; Vujcic L; Manischewitz J; Golding H
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1139-46. PubMed ID: 1380260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells.
    De Jong J; Simon F; Van der Groen G; Baan E; Saragosti S; Brun-Vézinet F; Goudsmit J
    AIDS Res Hum Retroviruses; 1996 Nov; 12(16):1503-7. PubMed ID: 8911575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficient inhibition of both syncytium-inducing and non-syncytium-inducing wild-type HIV-1 by lamivudine in vivo.
    van 't Wout AB; Ran LJ; Nijhuis M; Tijnagel JM; de Groot T; van Leeuwen R; Boucher CA; Schuitemaker H; Schuurman R
    AIDS; 1998 Jul; 12(10):1169-76. PubMed ID: 9677166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of apoptosis by primary HIV-1 isolates correlates with productive infection in peripheral blood mononuclear cells.
    Zhang YJ; Fadeel B; Hodara V; Fenyö EM
    AIDS; 1997 Aug; 11(10):1219-25. PubMed ID: 9256939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The biological phenotype of HIV-1 is usually retained during and after sexual transmission.
    Fiore JR; Björndal A; Peipke KA; Di Stefano M; Angarano G; Pastore G; Gaines H; Fenyö EM; Albert J
    Virology; 1994 Oct; 204(1):297-303. PubMed ID: 8091660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.